Run group: Approval notice for market application of chemical raw materials for ammonium glucosamine chloride sodium complex salt obtained.

Run Du Corporation announced that the company recently received the "Chemical Active Pharmaceutical Ingredient Market Application Approval Notice" for the Glucosamine Sulfate Sodium Chloride complex salt issued by the National Medical Products Administration. This drug is used to treat primary and secondary osteoarthritis, and its approval further enriches the company's product range, which is beneficial for enhancing the company's market competitiveness and positively impacting its future business performance. However, the future market sales may be affected by various uncertain factors such as policy environment, market changes, etc., leading to uncertainty.